Aldeyra Therapeutics ALDX
NASDAQ ALDX
$0.69 -0.05 (-6.25%)
As of: Oct 21, 2026 · 1:47 PM EDT

Aldeyra Therapeutics (ALDX) Acquisitions (2019)

Updated

Aldeyra Therapeutics (ALDX) recorded Acquisitions of -$22,626 in Q4 2019.

Analysis

Aldeyra Therapeutics (ALDX) Acquisitions (2019) Analysis & Trends

For FY2019, Aldeyra Therapeutics reported Acquisitions of $609,464.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,134.13 Bn 1,102.72 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 616.20 Bn 534.73 Bn 17.26 Bn -17.24 Bn
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn -
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn -
5 Novartis Ag 297.88 Bn 261.87 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 261.36 Bn 235.05 Bn 12.86 Bn -
7 Amgen 235.80 Bn 191.20 Bn 7.24 Bn -
8 Gilead Sciences 190.78 Bn 164.97 Bn 6.22 Bn 11.21 Bn
9 Pfizer 169.43 Bn 116.08 Bn 10.94 Bn -
10 Aldeyra Therapeutics 41.53 Mn -213.90 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 22,626.00
Sep 30, 2019 -69,728.00
Mar 31, 2019 -562,362.00
API Access

Aldeyra Therapeutics Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=ALDX&period=max&api_key=YOUR_API_KEY